Diabetes Drugs Flashcards

(44 cards)

1
Q

example of biguanide

A

metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

first line treatment

A

metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

mechanism of action of metformin

A

reduce gluconeogenesis
suppress hepatic glucose output
increase fatty acid oxidation
increase insulin sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

benefits of metformin

A

manages hyperglycaemia
does not cause hypoglycaemia
weight neutral
reduces triglycerides and LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

complications prevented by metformin

A

microvascular

macrovascular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

is metformin safe in pregnancy

A

yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

other conditions which may benefit from metformin therapy

A

PCOS

NAFLD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

adverse effects of metformin

A

GI upset
interferes with B12 and folic acid absorption
lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

when is lactic acidosis more likely

A

existing renal or hepatic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

2nd line treatment

A

sulphonylureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

examples of first gen SUs

A

tolbutamide

chlorpropramide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

examples of second gen SUs

A

gliclazide
glipizide
glibencamide
glimepride

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

mechanism of action of SUs

A

close ATP sensitive K+ channels on B cells

promotes Ca2+ influx which signals insulin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

benefits of SUs

A

manages hyperglycaemia

more rapid reduction in hyperglycaemia than insulin sensitisers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

adverse effects of SUs

A
hypoglycaemia 
weight gain 
GI upset 
headache 
avoid in severe renal or hepatic failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

example of thiazolidinediones

A

pioglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

mechanism of action of pioglitazone

A

lipophilic so enters cells and binds to PPARy
PPARy complexed with RXR
transcription modulator binds to DNA to promote expression of genes encoding proteins involved in insulin signalling
promote fatty acid uptake in adipocytes
reduce hepatic glucose output
increase insulin sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

benefits of TZDs

A

manages hyperglycaemia

no hypoglycaemia

19
Q

complications prevented by SUs

A

microvascular

20
Q

adverse effects of TZDs

A

weight gain

increased risk of hip fracture (osteoporosis)

21
Q

contraindications to TZDs

A

heart failure

osteoporosis

22
Q

complications prevented by TZDs

A

macrovascular

23
Q

what do incretin hormones do

A

control the effect sugar has on the GI tract
slow gastric emptying to increase satiety
stimulate insulin secretion
reduce hepatic glucose output
decrease glucagon production
make beta cell more sensitive to glucose

24
Q

2 therapies based on incretins

A

GLP 1 receptor agonists

DPP 4 inhibitors

25
examples of GLP 1 agonists
exenatide liraglutide lixisenatide
26
mechanism of action of GLP 1 agonists
mimic action of GLP 1 bind to GPCR which increase intracellular cAMP concentration acts as incretin hormones do reduce hepatic fat accumulation
27
benefits of GLP 1 agonists
promote insulin secretion from pancreas without hypoglycaemia modest weight loss reduce appetite
28
adverse effects of GLP 1 agonists
nausea | pancreatitis
29
examples of DPP 4 inhibitors
sitagliptin vildagliptin saxagliptin linagliptin
30
mechanism of action of DPP 4 inhibitors
also manipulate the incretin pathway but less potent than GLP 1 agonists inhibits enzyme DPP4, thus prolonging the actions of GLP1 and GIP
31
benefits of DPP4 inhibitors
promote insulin secretion without hypoglycaemia weight neutral limited side effects as not that potent
32
side effects of DPP4 inhibitors
rarely pancreatitis
33
examples of SGLT2 inhibitors
dapagliflozin
34
mechanism of action of SGLT2 inhibitors
selectively block reabsorption of glucose by SGLT2 in the proximal tubule of the kidney nephron to deliberately cause glycosuria
35
benefits of SGLT2 inhibitors
weight loss no hypoglycaemia cardiovascular benefit
36
adverse effects of SGLT 2 inhibitors
sugar in urine creates ideal conditions for bacterial or fungal overgrowth so thrush is a side effect
37
examples of alpha-glucosidase inhibitors
acarbose
38
mechanism of action of acarbose
delay absorption of glucose thus reducing postprandial increase in blood glucose stops the enzyme which mediates the final step in carbohydrate digestion
39
benefits of acarbose
no risk of hypoglycaemia
40
adverse effects of acarbose
abdominal discomfort, flatulence, diarrhoea
41
drugs which increase secretion of insulin | action is insulin dependent
SUs incretin mimetics glinides DPP4 inhibitors
42
drugs which decrease insulin resistance and reduce hepatic glucose output action is insulin dependent
biguanides | TZDs
43
drugs which slow glucose absorption from the GI tract | action is insulin independent
alpha-glucosidase inhibitors
44
drugs which enhance glucose excretion by kidneys | action is insulin independent
SGLT2 inhibitors